Apyx Medical Corp. (APYX)

3.95 +0.08 (+2.07%) USD  |  NASDAQ  |  May 19, 16:00
3.95 0.00 (0.00%) After-Hours: 20:00
More

Apyx Medical Research and Development Expense (Quarterly) : 0.765M for March 31, 2026

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for APYX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
LeMaitre Vascular, Inc. 4.06M
Abbott Laboratories 767.00M
AngioDynamics, Inc. 7.084M
Accuray, Inc. 8.178M
Alphatec Holdings, Inc. 17.56M